New US patent approval for Episurf Medical
Episurf Medical (NASDAQ: EPIS B) has received another Notice of Allowance from the United States Patent and Trademark Office (USPTO). The patent, entitled “System of designing a guide tool and/or surgical kit tools and/or an implant comprising a positioning mark” covers specific features for accurate positioning of Episurf Medical’s individualised joint implants. "This patent contributes to the IP protection for the Episealer® implant, which we have developed for the knee joint as well as the ankle”, comments Katarina Flodström, COO, Episurf Medical.